Identification
Properties
Safety Data
Specifications andamp ; Other Information
Links
Identification
CAS Number
129580-63-8
Name
Satraplatin
Synonyms
Acetic acid, compd. with cyclohexanamine, platinum(4+) salt, hydrochloride, ammoniate (2:1:1:2:1) [
ACD/Index Name] Chlorure acétate de platine(4+) – cyclohexanamine, ammoniate (2:2:1:1:1) [French] [
ACD/
IUPAC Name] Platin(4+)chloridacetat -cyclohexanaminammoniat (1:2:2:1:1) [German] [
ACD/
IUPAC Name] Platinum(4+) chloride acetate cyclohexanamine ammoniate (1:2:2:1:1) [
ACD/
IUPAC Name] (
OC-6-43)-Bis(acetato-0)ammine-dichloro(cyclohexanamine)Platinum (
IV) [129580-63-8] 129580-63-8 [
RN] 367265-85-8 [
RN] Bisacetatoammine-dichloro(cyclohexanamine)Platinum (
IV) bis-acetatoamminedichlorocyclohexylamine platinum(
IV)
C081294 Cyclohexanamine, platinum complex
JM216 MFCD00871429 platinum(4+) ion cyclohexanamine diacetate amine dichloride platinum(4+) ion cyclohexylamine diacetate amine dichloride Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (
OC-6-43)- Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (
OC-6-43)- Poplat Satraplatin
UNII :
8D7B37T28G UNII-8D7B37T28G Molecular Structure
Structure of Satraplatin CAS 129580-63-8
SMILES
CC(=O)[O-].
CC(=O)[O-].
C1CCC(
CC1)N.N.[Cl-].[Cl-].[Pt+4]
StdInChI
InChI=
1S/
C6H13N.
2C2H4O2.2ClH.
H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,
7H2;2*
1H3,(H,3,4);2*
1H ;
1H3;/q;;;;;;+4/p-4
StdInChIKey
CKNPWBAXEKSCRG-UHFFFAOYSA-J Molecular Formula
C10H22Cl2N2O4Pt
Molecular Weight
500.28
Properties
Appearance
Light yellow and odorless crystalline
Specifications and Other Information of Our Satraplatin CAS 129580-63-8
Standard
Enterprise standard
Identification Methods
HPLC,
IR Assay
98.0%~102.0%
Acidity
5.5~6.5
Related substance
If impurity peak appears in
HPLC, the sum of impurities peaks should be not more than the area of
RS main peak 2.0%
Loss on Drying
≤0.5%
Pt content(Gravimetric method)
38.7%~39.3%
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as the
API for treatment of lung and ovarian cancers
Links
This product is developed by our
RD company Caming Pharmaceutical Ltd(
http://www.caming.com), and here is the corresponding link
http://caming.com/satraplatin-cas-129580-63-8/